inHEART raises €3.7 million for 3D cardiac imaging
inHEART, a medical imaging solution provider for cardiac interventions, has closed a round of €3.7 million led by Elaia
Europe
Brainlab spawns Snke OS for surgery tech
Brainlab launches Snke OS to enable third parties to develop new surgical applications
EU agrees COVID-19 contact tracing framework
EU member states agreed on technical specifications for the safe exchange of data between national contact tracing apps.
Signum Surgical wins €3.6 million grants for colorectal disease therapy
Signum Surgical, which is developing minimally invasive technologies to treat colorectal diseases, has secured two grants totalling €3.6 million: €2.3 million from the EU Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund.
Peripal device approved in Europe for at-home peritoneal dialysis
Renal insufficiency is an expensive condition to treat due to the high cost of hospital dialysis treatment. Peripal AG, a Swiss startup, has received approval for the European market for its PeriSafe device for at-home dialysis.
Healthcare is primary focus for European AI companies
MMC Ventures, which invests in AI companies, has published its State of AI 2019 report, revealing rapid recent progress in AI adoption in healthcare.
Rare Disease Day: EU Platform on Rare Diseases Registration to address data fragmentation
The European Commission is launching a new online knowledge-sharing platform to support better diagnosis and treatment for more than 30 million Europeans living with a rare disease.
First EU citizens using cross-border ePrescriptions
The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country. Finnish citizens are now able to retrieve medicine prescribed by a doctor in Finland from a pharmacy in Estonia with ePrescriptions.
WeHealth by Servier and Pathmaker Neurosystems collaborating to treat spasticity
WeHealth by Servier and Pathmaker Neurosystems have formed a partnership to develop and commercialise Pathmaker’s MyoRegulator device, a non-invasive treatment for spasticity.
JPND announces €30 million call for neurodegenerative disease research
JPND, the EU’s neurodegenerative disease research initiative, has announced a €30 million call for multinational research on personalised medicine for neurodegenerative diseases.